S&P 500
(-0.44%) 5 049.27 points
Dow Jones
(-0.85%) 38 134 points
Nasdaq
(-0.72%) 15 600 points
Oil
(0.23%) $83.00
Gas
(-1.75%) $1.624
Gold
(0.20%) $2 343.10
Silver
(0.04%) $27.36
Platinum
(0.85%) $923.55
USD/EUR
(-0.27%) $0.932
USD/NOK
(-0.17%) $10.96
USD/GBP
(-0.43%) $0.799
USD/RUB
(-0.04%) $92.28

Realtime updates for Advicenne SA [ADVIC.PA]

Exchange: EURONEXT Industry: Biotechnology
Last Updated31 Dec 1970 @ 19:00

0.00% 6.50

Live Chart Being Loaded With Signals

Commentary (31 Dec 1970 @ 19:00):

Advicenne S.A. develops therapeutics for the treatment of rare kidney diseases. Its lead product candidate is ADV7103 for the treatment of distal renal tubular acidosis in children and adults, as well as for the treatment of cystinuria, an inherited renal tubulopathy...

Stats
Today's Volume 63 830.00
Average Volume 45 756.00
Market Cap 0.00
Last Dividend €0 ( N/A )
Next Dividend €0 ( N/A )
P/E -3.67
ATR14 €0 (0.00%)

Advicenne SA Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Advicenne SA Financials

Annual 2022
Revenue: €2.94M
Gross Profit: €1.83M (62.05 %)
EPS: €-1.160
Q2 2023
Revenue: €851 000
Gross Profit: €566 000 (66.51 %)
EPS: €-0.190
Q1 2023
Revenue: €851 000
Gross Profit: €566 000 (66.51 %)
EPS: €-0.190
Q4 2022
Revenue: €518 499
Gross Profit: €267 999 (51.69 %)
EPS: €-0.340

Financial Reports:

No articles found.

Advicenne SA

Advicenne S.A. develops therapeutics for the treatment of rare kidney diseases. Its lead product candidate is ADV7103 for the treatment of distal renal tubular acidosis in children and adults, as well as for the treatment of cystinuria, an inherited renal tubulopathy. The company also provides ADV6209, an oral liquid solution for children to reduce anxiety and to improve their immobility. Advicenne S.A. was founded in 2007 and is based in Paris, France.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators